ReviveMed Analysis: $6M Raised
What is ReviveMed?
ReviveMed utilizes AI to analyze metabolites for precision medicine, focusing on oncology and metabolic health. Their platform creates digital metabolic twins to predict disease outcomes and treatment responses. The company aims to enhance patient treatment through partnerships and innovative clinical trial designs.
Location
245 1st St, Cambridge, Massachusetts 02142, United States
Employees
11-50
Founded
2019
Product Features & Capabilities
- AI-based platform for metabolomics
- Digital metabolic twins for obesity
- Predictive models for immunotherapy response
- Multi-modal metabolomics data analysis
- Virtual patient simulations for clinical trials
Use Cases
Predict metabolic health risks beyond BMI; Identify patients likely to benefit from immunotherapy; Simulate clinical trial outcomes with virtual patients; Analyze blood metabolites for cancer treatment insights; Develop targeted therapeutic strategies based on metabolomics
How much ReviveMed raised
Funding - $6M
Other Considerations
Developed at MIT and published in Nature Methods; Recognized for first-in-class generative models in metabolomics; Collaborations with various healthcare and research institutions
See something that needs updating? Suggest edits to this profile.